Global Adjuvants Market: Overview
Adjuvant oncology treatment is a part of cancer therapeutics, which entails further cancer treatment after the completion of the primary treatment. Its main aim is to reduce the risk of the cancer coming back again. Adjuvant therapy includes radiation therapy, chemotherapy, targeted therapy, hormone therapy, or biological therapy. Oncologists take into consideration various factors, such as statistical evidence, before zeroing in on the suitable adjuvant therapy.
The primary aim of adjuvant therapy is to increase chances of survival of cancer patients by eliminating the risk of cancer relapsing. It is typically provided after treatment of various kinds of cancers, such as colon, lung, prostate, breast, and others forms of gynecological cancers through oncological surgeries and adjuvant therapy. However, it is ineffective in cases of renal carcinoma and a few kinds of brain cancer.
The report presents an in-depth overview on the global adjuvants market after extensive research. It utilizes both historical and current data to predict the growth prospects in the market. By segmenting the worldwide market based on various parameters and implementing various analytical tools such as SWOT analysis and Porter’s Five Forces, the report gauges the competitive dynamics prevalent in the market.
Global Adjuvants Market: Trends and Opportunities
The primary growth driver in the global market for adjuvant oncology treatment is the rising instances of cancer worldwide. This, alongside many positive initiatives adopted by governments and insurance companies for reimbursing the treatment cost of cancers, has provided a major fillip to the market. Further, an increasing thrust on research initiatives and efforts to uncover more maladies that could be treated with adjuvant therapy are slated to propel the market growth in the upcoming years.
The report classifies the overall market for oncology adjuvants depending upon the applications and various types of cancers they are used to treat. By doing so, the report tries to understand where maximum opportunity lies in the market. Based on applications, for example, it segments the market for adjuvants into immunotherapy, chemotherapy, radiotherapy, and others. Based on diseases treated through adjutants, it classifies the market into sarcoma, breast cancer, Hodgkin’s lymphoma, colorectal cancer, glioblastoma, prostate cancer, lung cancer, and ovarian cancer. Breast cancer accounts for a major chunk of the revenue in the market at present and going forward, it would only up the current figures. In terms of growth rate, however, colorectal cancer will likely outshine all other segments.
Global Adjuvants Market: Regional Outlook
Geography-wise, the report divides the market into Asia Pacific, Europe, North America, and the Rest of the World. Among them, Europe and North America are the dominant markets for adjuvants. This is because of the high prevalence of cancer in the two continents. Other factors boosting these markets are the developed healthcare facilities, favorable reimbursements policies, and the greater means of people to spend on better quality healthcare. Knowledge of the disease and its various treatments is also at the forefront of driving the growth of the two regional markets. Corroborating the fact is the finding of World Health Organization (WHO), which states that about 75% countries worldwide have reported having generally available cancer treatment services that include cancer surgery, subsidized chemotherapy and cancer centers or departments. In Europe, an impressive 90% of countries reported having these cancer treatment services generally available.
Asia Pacific follows North America and Europe in terms of market share. The emerging economies of India and China with their massive populations are major growth drivers in the region. Rising instances of cancer and rapidly developing healthcare infrastructure, coupled with the rise in medical tourism in the region, have stimulated the growth of the market so far. In the near future too, the region will exhibit promising growth on account of a flurry of research initiatives due to the availability affordable human resources and helpful government policies.
Companies Mentioned in the Report
To present a proper assessment of the existing competition in the global market, the report has profiled some of the key companies operating in the market such as Eli Lilly Co., Amgen, Inc., BMS, Biogen, Sanofi, AstraZeneca PLC, and Pfizer, Inc. It studies the sales, revenues, market shares, and growth prospects of each of the players, besides throwing light on their key strategies.
Global Adjuvant Market, by Geography
- North America
- Asia Pacific
- Rest of the World
This report gives you access to decisive data such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.